Journal of Rhinology 2013;20(1):8-13.
Published online May 31, 2013.
Obstructive Sleep Apnea and Systemic Diseases
Ji Hun Mo
Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea. jihunmo@gmail.com
수면무호흡과 전신질환
모지훈
단국대학교 의과대학 이비인후과학교실
Abstract
As society industrializes and develops, people become increasingly concerned about quality of life and sleep-related disorders. Sleep disordered breathing (SDB) includes obstructive sleep apnea (OSA) and upper airway resistance syndrome. Most of the patients that snore have OSA, and OSA can result in not only cardiovascular and neuro-cognitive diseases but also in severe morbidities and mortalities; therefore, its importance cannot be emphasized too strongly. The mechanism by which OSA induces such morbidities is related to sleep fragmentation and intermittent hypoxia, which result in sympathetic activation, endothelial dysfunction, and metabolic dysregulation. All of these conditions produce a humoral imbalance, a hypercoagulable state, and atherosclerosis, which finally result in multi-morbidities. These comorbidities include cardiovascular, respiratory, neurologic, metabolic, and genitourinary disorders. The clinical relevance of OSA is mainly due to its strong association with morbidities such as hypertension, metabolic syndrome, diabetes, heart failure, coronary artery disease, arrhythmias, stroke, pulmonary hypertension, and neurocognitive and mood disorders. A high mortality rate has also been associated with OSA. It is important to acknowledge the comorbidities of OSA to achieve a better understanding of the disease and for better treatment of patients with OSA. In this review, the comorbidities of OSA will be discussed in detail.
Key Words: Obstructive Sleep Apnea;Comorbidity;Hypertension;Stroke;Diabetes


TOOLS
  • PDF LinksPDF Links
  • Full text via DOI   Full text via DOI
  • Download Citation Download Citation
  •    Share :  Facebook Twitter Linked In
METRICS Graph View
  • 2,010 View
  • 6 Download
Related articles

Effects of Particulate Matter on Obstructive Sleep Apnea and Obesity2025 July;32(2)

Weight Loss for Obstructive Sleep Apnea: Pharmacological and Surgical Management2023 March;30(1)

Surgical Management of Obstructive Sleep Apnea Syndrome 1994 November;1(2)

Pathogenesis of Obstructive Sleep Apnea2009 November;16(2)

Vitamin D and Allergic Disease2014 November;21(2)



Editorial Office
101 Hyundai ESA Apt., 20, Hyoryeong-ro 77-gil, Seocho-gu, Seoul 06628, Republic of Korea
Tel: +82-2-3461-9945    Fax: +82-2-3461-9947    E-mail: office@j-rhinology.org                

Copyright © 2026 by Korean Rhinologic Society.

Developed in M2PI

Close layer
prev next